Efflux of Zidovudine and 2′,3′-Dideoxyinosine Out of the Cerebrospinal Fluid When Administered Alone and in Combination to Macaca nemestrina
- 1 January 1994
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 11 (2) , 312-317
- https://doi.org/10.1023/a:1018928013044
Abstract
To determine if there is active efflux of zidovudine (ZDV) and 2′,3′-dideoxyinosine (ddl) out of the cerebrospinal fluid (CSF), and if this efflux is saturable, we investigated the steady-state CSF/plasma concentration ratio of the two drugs when administered alone or in combination. Constant-rate infusions of ZDV, ddl or both were administered to seven macaques (Macaca nemestrina) through a chronic venous catheter for a minimum of 28 hr. Antipyrine, a marker of passive diffusion, was coinfused in all experiments. Blood (5 mL) and CSF samples (0.5–1 mL) were collected by venous and lumbar/thoracic punctures, respectively, at 24 and 28 hr after beginning the infusion. When ZDV and ddl were administered alone, the steady-state CSF/plasma concentration ratios were significantly different from unity (ZDV, 0.20 ± 0.08; ddI, 0.09 ± 0.04) and were independent of the plasma concentration (P > 0.05). In contrast, the CSF/plasma concentration ratio of antipyrine (0.82 ± 0.19) was close but significantly smaller than unity (P > 0.05). The CSF/ plasma concentration ratios after simultaneous administration of ZDV and ddI were not significantly different (P > 0.05) from those obtained after administration of the drugs alone. These results suggest that ZDV and ddI are actively transported out of the CSF; however, within the concentration range studied, this efflux is neither saturable nor mutually competitive. Concomitant administration of ZDV and ddI did not produce a systemic interaction in the animals, indicating that the pharmacokinetics of either drug is unaffected by the presence of the other.Keywords
This publication has 27 references indexed in Scilit:
- Clinical Response to Dideoxyinosine in Patients with HIV Infection Resistant to ZidovudineNew England Journal of Medicine, 1990
- Once-Daily Administration of 2′,3′-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related ComplexNew England Journal of Medicine, 1990
- The Mammalian Choroid PlexusScientific American, 1989
- Declining incidence of AIDS dementia complex after introduction of zidovudine treatment.BMJ, 1989
- Effect of Probenecid on the Renal and Nonrenal Clearances of Zidovudine and Its Distribution into Cerebrospinal Fluid in the RabbitJournal of Pharmaceutical Sciences, 1989
- HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged TherapyScience, 1989
- Restricted Transport of 3'-Azido-3'-Deoxythymidine and Dideoxynucleosides Through the Blood-Brain BarrierThe Journal of Infectious Diseases, 1988
- Review of central nervous system pathology in human immunodeficiency virus infectionAnnals of Neurology, 1988
- Probenecid-induced accumulation of 5-hydroxyindoleacetic acid and homovanillic acid in rat brainJournal of Pharmacy and Pharmacology, 1987
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987